论文部分内容阅读
腹膜透析(腹透)是终末期肾病患者肾脏替代治疗的有效方式之一,但传统腹透液的生物不相容性使腹透寿命受到限制。有研究发现,生物相容性腹透液对终末期肾病患者的影响优于传统腹透液。该文就生物相容性腹透液对终末期肾病患者残余肾功能、腹膜功能、腹膜炎发生率、技术失败、全因死亡等方面影响的研究进展进行了综述。
Peritoneal dialysis (peritoneal dialysis) is one of the effective ways of renal replacement therapy in patients with end-stage renal disease. However, the biological incompatibility of traditional peritoneal dialysis limits the life expectancy of peritoneal dialysis. Some studies have found that biocompatible peritoneal fluid in patients with end-stage renal disease than traditional peritoneal dialysis fluid. This review summarizes the research progress of biocompatible peritoneal dialysis on the residual renal function, peritoneal function, incidence of peritonitis, technical failure and all-cause mortality in patients with end-stage renal disease.